Company profile for Boan Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 2013 as a holding subsidiary of Luye Pharma Group, Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) is a fully integrated biopharmaceutical company. It specializes in therapeutic antibody development with a focus on oncology, immunology, pain, and endocrine diseases. Boan Biotech’s antibody discovery work is based on three technology platforms: Human Antibody Transgenic Mouse and Phage Display Technology, ...
Established in 2013 as a holding subsidiary of Luye Pharma Group, Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) is a fully integrated biopharmaceutical company. It specializes in therapeutic antibody development with a focus on oncology, immunology, pain, and endocrine diseases. Boan Biotech’s antibody discovery work is based on three technology platforms: Human Antibody Transgenic Mouse and Phage Display Technology, Bispecific T-cell Engager Technology, and ADC Technology. Through leveraging its efficient and innovative capabilities, the company has developed more than 10 innovative antibody product candidates

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
39 Keji Avenue, hi tech Zone, Yantai City, Shandong Province
Telephone
Telephone
(86)0535-4379111
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.asiaone.com/business/first-patient-enrolled-phase-iii-clinical-trial-boan-biotechs-nivolumab-injection

ASIAONE
30 Oct 2023

https://www.clinicaltrialsarena.com/news/chinas-nmpa-boan-biotechs-antibody-drug/

CLINICALTRIALSARENA
05 Oct 2021

https://www.prnewswire.com/news-releases/boan-biotech-to-present-the-pre-clinical-data-of-its-proprietary-cd3-t-cell-engager-platform-and-ceacd3-bispecific-antibody-at-world-bispecific-summit-301385115.html

PRNEWSWIRE
26 Sep 2021

https://www.luye.cn/lvye_en/view.php?id=1935

PRESS RELEASE
16 Jun 2021

https://en.prnasia.com/releases/apac/boan-biotech-grants-astrazeneca-exclusive-rights-to-promote-boyounuo-r-bevacizumab-injection-in-specific-county-markets-of-china-320006.shtml#:~:text=SHANGHAI%2C%20May%2026%2C%202021%20%2F,to%20the%20latter%20exclusive%20promotion

PRNASIA
26 May 2021

https://www.firstwordpharma.com/node/1804456

FIRSTWORLD PHARMA
25 Feb 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty